Trial Profile
N-Acetylcysteine to Prevent Contrast-Induced Nephropathy in Acute Coronary Syndromes
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs Acetylcysteine (Primary)
- Indications Kidney disorders
- Focus Therapeutic Use
- 19 Dec 2014 New trial record